Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Sex Workers, MSM, and Transgender Persons: Disruption in access to PrEP services, reduced capacity for HIV prevention services, , reduced availability of HIV counselling and testing, and disruption in ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

A South African Medical Research Council (SAMRC) study has revealed that HIV remains one of the leading causes of death in ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...

Dinas Kesehatan (Dinkes) Kabupaten Pamekasan, Jawa Timur menemukan sebanyak 28 kasus human immunodeficiency virus (HIV) ...

Hear.com can match you with basic, midrange and premium technology hearing aids. Verified customers tell us that the hearing aids are high quality and effectively improve their hearing.

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

The 2003 inception of the US President’s Emergency Plan for AIDS Relief, or PEPFAR, provided new hope for children living with HIV around the continent, including the orphans at Nyumbani.

an estimated 75.7 million people have been diagnosed with HIV worldwide, and 32.7 million people have died of AIDS-related illnesses. Global health organizations like the United Nations (UN) and the ...